Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Novartis purchases U.S. rights to Agomelatine

Posted by jrbecker on March 29, 2006, at 8:37:31

http://today.reuters.com/business/newsarticle.aspx?type=ousiv&storyID=2006-03-29T105511Z_01_L29268788_RTRIDST_0_BUSINESSPRO-NOVARTIS-DC.XML

article excerpt...

"BETTER ANTIDEPRESSANT?

The deal with Servier gives Novartis U.S. rights to agomelatine, a Phase III investigational drug for the treatment of major depressive disorder, which may have advantages over existing treatments.

Agomelatine has been filed for approval in Europe but Novartis will need to conduct a clinical trial program in the United States, which analysts said suggested sales were still a number of years away.

Industry analysts at Kepler Equities said agomelatine appeared to have similar efficacy to other antidepressants such as Wyeth's Effexor and GlaxoSmithKline's Paxil, but may have fewer side effects.

"The antidepressant market is crowded, so ultimate sales of agomelatine for Novartis will depend on the success of its clinical trial program," Kepler said in a note." "


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker thread:625983
URL: http://www.dr-bob.org/babble/20060329/msgs/625983.html